Commentary
VOLUME: 36 | ISSUE: 2S | Jun 24, 2020 | PAGE: (93 - 96) | DOI: 10.24911/BioMedica//BioMedica/5-392
Interpretation of Diagnostic Tests for COVID-19 (SARS-COV-2)
Authors: Sadaf Shafique , Farheen Aslam , Raheel Khan , Asma Shaukat
Article Info
Authors
Sadaf Shafique
Assistant Professor, Department of Pathology, Quaid-e-Azam Medical College, Bahawalpur– Pakistan.
Farheen Aslam
Assistant Professor, Department of Pathology, Quaid-e-Azam Medical College, Bahawalpur– Pakistan.
Raheel Khan
Department of Medicine, Quaid-e-Azam Medical College/Victoria Hospital, Bahawalpur– Pakistan.
Asma Shaukat
Professor, Department of Pathology, Quaid-e-Azam Medical College, Bahawalpur– Pakistan.
Publication History
Received: May 20, 2020
Revised: May 26, 2020
Accepted: June 19, 2020
Published: June 24, 2020
Abstract
The knowledge regarding diagnostic testing for SARS COV-2 is still at hit-and-trial phases, all over the world. Evolving day by day through ongoing research and extensive trials, use for SARS-COV-2 infectionsReverse Transcriptase-Polymerase Chain Reaction (RT-PCR) and IgM/ IgG serology by Enzyme Linked Immunosorbent Assay (ELISA) or Electro-Chemiluminescent Immunoassay remain the main stay of diagnosis. However, the time course for the PCR positivity and seroconversion seem to vary in children and adults both, which also includes a huge population of asymptomatic individuals who are potentially labelled negative hence posing a great threat to the surrounding community.
Keywords: SARS COV-2, Immunoglobulins, Enzyme Linked Immunosorbent Assay (ELISA).
